Correspondence: The use and harms of Cumyl-PeGaClone | GovWire News

Correspondence: The use and harms of Cumyl-PeGaClone

⌂Back To Homepage Subscribe To RSS Feed

Advisory Council On The Misuse Of Drugs

July 25

11:31 2023

Print This Article Share it With Friends

Created by Advisory Council On The Misuse Of Drugs 0 comments

Government response to the ACMDs advice on Cumyl-PeGaClone and other synthetic cannabinoid receptor agonists

HTML

Details

Government response to the Advisory Council on the Misuse of Drugs review of the evidence on the use and harms of Cumyl-PeGaClone.

Published 25 July 2023

Ministerial Departmental News

News Calendar

Recent Comments

Follow Us on Twitter

Tweets by @gov_wire